Is Aurora Spine Corporation (ASAPF) a Buy, Sell, or Hold?
Aurora Spine Corporation
OTC:ASAPF
$0.17319 USD
$0 (0.0%)
- Volume
- 1K
- Average Volume
- 32.57K
- Market Capitalization
- $13.52M
- P/E Ratio
- -22.94
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $0.26
- Year Low
- $0.15
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.53
Industry, Sector & symbol
| Stock Exchange | OTC |
| CEO | Trent J. Northcutt |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Current Symbol | ASAPF |
| CUSIP | 05206X108 |
| CIK | None |
| Web | https://www.aurora-spine.com |
| Phone | 760-424-2004 |
| Currency | USD |
| Employees | 18 |
| Country | CA |
Liquidity
| Debt-to-Equity Ratio | 0.62 |
| Payout Ratio | 0.00 |
| Current Ratio | 2.53 |
| Quick Ratio | 1.41 |
| Cash Ratio | 0.27 |
Sales & Book Value
| Annual Sales | $18.69M |
| Price / Sales | 0.74 |
| Cash Flow | 0.01 |
| Price / Cash Flow | 17.82 |
| Price / Book | 3.76 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Strong Sell |
| Rating Score(0-5) | 1 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.0095 |
| Trailing P/E Ratio | -22.94 |
| PEG Ratio | -1.35 |
| P/E Growth | -1.35 |
| Net Income | $-743.92K |
| Net Margin | -3.24% |
| Pretax Margin | -3.17% |
| Return on Equity | -15.61% |
| Return on Assets | -6.11% |
Financials Score
| AltmanZ Score | -0.30 |
| Piotroski Score | 5.00 |
| Working Capital | 4.42M |
| Total Assets | 9.74M |
| Ebit | -193.26K |
| Market Cap | 13.52M |
| Total Liabilities | 6.11M |
Poll Results
About Aurora Spine Corporation (OTC:ASAPF) Stock
Aurora Spine Corporation, operating through its subsidiary Aurora Spine, Inc., specializes in the development and distribution of advanced, minimally invasive spine fusion systems and related medical devices. The company's diverse product portfolio includes a range of interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTRA, ZIP LP, and ZIP-51 lines, specifically engineered to treat patients suffering from degenerative disc diseases. Additionally, Aurora Spine provides titanium-coated polyether ether ketone (PEEK) interbody cages. These cages are crucial for maintaining proper spacing and stability between spinal vertebrae, thereby encouraging bone growth to achieve successful fusion. Aurora Spine also supplies sterile, titanium plasma spray coated spinal implants designed to ... promote bone integration. Complementing these, it offers a suite of interbody products such as the EOS, VOX, Echo, Echo SD, and EchoXL series for lumbar applications, and the Discovery system for cervical surgeries. Among its innovations is SOLO, a 3D-printed, stand-alone anterior lumbar interbody fusion device. This integrated plate and spacer system is designed to maintain the spine's natural anatomical alignment while delivering essential support and stability to the spinal column. Another key offering is SiLo, a posterior fusion device specifically developed for the sacroiliac joint. Furthermore, the DEXA-C cervical interbody system stands out as a porous, 3D-printed intervertebral body fusion device. It features customizable low-, mid-, or high-density lattice patterns, allowing for precise matching with individual patient bone quality. Established in 2013, Aurora Spine Corporation has its corporate headquarters situated in Toronto, Canada.
Aurora Spine Grants Stock Options
2026-06-09 18:07:00
Carlsbad, California--(Newsfile Corp. - June 9, 2026) - Aurora Spine Corporation (TSXV: ASG) (OTCQB: ASAPF) ("Aurora Spine" or the "Company"), a leader
Aurora Spine Corporation (ASG:CA) Q1 2026 Earnings Call Transcript
2026-05-28 22:44:06
Aurora Spine Corporation (ASG:CA) Q1 2026 Earnings Call Transcript
Aurora Spine Corporation Announces First Quarter FY26 Financial Results
2026-05-28 07:15:00
- Company to host conference call Today, May 28th at 10am ET/7am PT – - Company to host conference call Today, May 28th at 10am ET/7am PT –
Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2026 Financial Results
2026-05-26 17:16:14
CARLSBAD, Calif. , May 26, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced it will file its financial results with SEDAR for its first quarter of fiscal year 2026 for the period ended March 31, 2026, on Wednesday, May 27, 2026, after market hours.
Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2026 Financial Results
2026-05-26 17:16:00
- Company to Participate in the Lytham Partners Spring 2026 Investor Conference - - Company to Participate in the Lytham Partners Spring 2026 Investor Conference -
2026-05-07 07:15:00
CARLSBAD, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced the issuance of its fourth U.S. patent related to Aurora's proprietary DEXA Technology® platform.
2026-05-07 07:15:00
CARLSBAD, Calif. , May 07, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced the issuance of its fourth U. S. patent related to Aurora's proprietary DEXA Technology platform.
Aurora Spine Corporation (ASG:CA) Q4 2025 Earnings Call Transcript
2026-04-30 17:31:37
Aurora Spine Corporation (ASG:CA) Q4 2025 Earnings Call Transcript
Frequently Asked Questions
-
What is the current Aurora Spine Corporation (ASAPF) stock price?
-
Aurora Spine Corporation(OTC:ASAPF) stock price is $0.17319 in the last trading session. During the trading session, ASAPF stock reached the peak price of $0.2563 while $0.14895 was the lowest point it dropped to. The percentage change in ASAPF stock occurred in the recent session was 0.0% while the dollar amount for the price change in ASAPF stock was $0.
-
ASAPF's industry and sector of operation?
-
The OTC listed ASAPF is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of ASAPF?
-
Matthew Goldstone | Chief Commercial Officer
Laszlo Garamszegi | Chief Technology Officer & Founder
Trent J. Northcutt | Founder, President, Chief Executive Officer & Director
Matt Paxton | Executive Vice President of Sales
Chad Clouse | Chief Financial Officer -
How many employees does ASAPF have?
-
Number of ASAPF employees currently stands at 18. ASAPF operates from 20 Holly Street, Toronto, ON M4S 3B1, CA.
-
Link for ASAPF official website?
-
Official Website of ASAPF is: https://www.aurora-spine.com
-
How do I contact ASAPF?
-
ASAPF could be contacted at phone #760-424-2004 and can also be accessed through its website. ASAPF operates from 20 Holly Street, Toronto, ON M4S 3B1, CA.
-
How many shares of ASAPF are traded daily?
-
The average number of ASAPF shares traded daily for last 3 months was 32.57K.
-
What is the market cap of ASAPF currently?
-
The market value of ASAPF currently stands at $13.52M with its latest stock price at $0.17319